FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2036637468> ?p ?o ?g. }

• W2036637468 endingPage "986" @default.
• W2036637468 startingPage "982" @default.
• W2036637468 abstract "SummaryElevated levels of soluble uPAR (s-uPAR) and other fibrinolytic parameters functionally related to the urokinase-type plasminogen activator system might indicate the presence of cancer cells. In 25 breast cancer patients with metastases s-uPAR was significantly increased compared with 25 patients without metastases and with 25 healthy controls: 420 pg mL−1 vs. 145 pg mL−1 (P = 0.005) and 190 pg mL−1 (P = 0.003). Plasmin–α2-antiplasmin (PAP) complexes and d-dimers were significantly increased in breast cancer patients with metastases compared with patients without metastases and with healthy controls. The levels of plasminogen activator inhibitor (PAI)-1 activity, uPA antigen and factor (F)XIIa did not significantly differ between the patient groups and healthy controls. PAP complexes (529 µg L−1 vs. 420 µg L−1; P = 0.03), d-dimers (278.5 ng mL−1 vs. 79.0 ng mL−1; P = 0.005) and FXIIa (1.64 ng mL−1 vs. 1.19 ng mL−1; P = 0.01) were significantly higher in patients with metastases not surviving compared with patients with metastases surviving the 3-year follow-up period. Plasma s-uPAR levels in the patients with metastases did not discriminate between patients surviving and patients not surviving after 3-year follow-up. No significant differences in s-uPAR or any of the other parameters were found in the five patients developing metastases during follow-up. A single value of s-uPAR is of limited value in the follow-up of breast cancer patients with and without metastatic disease and does not predict survival or future metastases. Elevated levels of soluble uPAR (s-uPAR) and other fibrinolytic parameters functionally related to the urokinase-type plasminogen activator system might indicate the presence of cancer cells. In 25 breast cancer patients with metastases s-uPAR was significantly increased compared with 25 patients without metastases and with 25 healthy controls: 420 pg mL−1 vs. 145 pg mL−1 (P = 0.005) and 190 pg mL−1 (P = 0.003). Plasmin–α2-antiplasmin (PAP) complexes and d-dimers were significantly increased in breast cancer patients with metastases compared with patients without metastases and with healthy controls. The levels of plasminogen activator inhibitor (PAI)-1 activity, uPA antigen and factor (F)XIIa did not significantly differ between the patient groups and healthy controls. PAP complexes (529 µg L−1 vs. 420 µg L−1; P = 0.03), d-dimers (278.5 ng mL−1 vs. 79.0 ng mL−1; P = 0.005) and FXIIa (1.64 ng mL−1 vs. 1.19 ng mL−1; P = 0.01) were significantly higher in patients with metastases not surviving compared with patients with metastases surviving the 3-year follow-up period. Plasma s-uPAR levels in the patients with metastases did not discriminate between patients surviving and patients not surviving after 3-year follow-up. No significant differences in s-uPAR or any of the other parameters were found in the five patients developing metastases during follow-up. A single value of s-uPAR is of limited value in the follow-up of breast cancer patients with and without metastatic disease and does not predict survival or future metastases." @default.
• W2036637468 created "2016-06-24" @default.
• W2036637468 creator A5012257541 @default.
• W2036637468 creator A5029495450 @default.
• W2036637468 creator A5045159675 @default.
• W2036637468 creator A5067403552 @default.
• W2036637468 creator A5072170382 @default.
• W2036637468 creator A5075635630 @default.
• W2036637468 date "2003-05-01" @default.
• W2036637468 modified "2023-10-18" @default.
• W2036637468 title "The prognostic value of the soluble urokinase-type plasminogen activator receptor (s-uPAR) in plasma of breast cancer patients with and without metastatic disease" @default.
• W2036637468 cites W1822598714 @default.
• W2036637468 cites W1966719969 @default.
• W2036637468 cites W1984533079 @default.
• W2036637468 cites W1991962266 @default.
• W2036637468 cites W1995406904 @default.
• W2036637468 cites W2002951101 @default.
• W2036637468 cites W2005113904 @default.
• W2036637468 cites W2028513701 @default.
• W2036637468 cites W2029837224 @default.
• W2036637468 cites W2052492883 @default.
• W2036637468 cites W2150776809 @default.
• W2036637468 cites W2197375803 @default.
• W2036637468 cites W2200649958 @default.
• W2036637468 cites W2204865615 @default.
• W2036637468 cites W2313628137 @default.
• W2036637468 cites W2405442768 @default.
• W2036637468 cites W2412055773 @default.
• W2036637468 cites W4300014906 @default.
• W2036637468 doi "https://doi.org/10.1046/j.1538-7836.2003.00207.x" @default.
• W2036637468 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12871365" @default.
• W2036637468 hasPublicationYear "2003" @default.
• W2036637468 type Work @default.
• W2036637468 sameAs 2036637468 @default.
• W2036637468 citedByCount "16" @default.
• W2036637468 countsByYear W20366374682012 @default.
• W2036637468 countsByYear W20366374682014 @default.
• W2036637468 countsByYear W20366374682015 @default.
• W2036637468 countsByYear W20366374682016 @default.
• W2036637468 countsByYear W20366374682018 @default.
• W2036637468 countsByYear W20366374682021 @default.
• W2036637468 countsByYear W20366374682022 @default.
• W2036637468 crossrefType "journal-article" @default.
• W2036637468 hasAuthorship W2036637468A5012257541 @default.
• W2036637468 hasAuthorship W2036637468A5029495450 @default.
• W2036637468 hasAuthorship W2036637468A5045159675 @default.
• W2036637468 hasAuthorship W2036637468A5067403552 @default.
• W2036637468 hasAuthorship W2036637468A5072170382 @default.
• W2036637468 hasAuthorship W2036637468A5075635630 @default.
• W2036637468 hasBestOaLocation W20366374681 @default.
• W2036637468 hasConcept C121608353 @default.
• W2036637468 hasConcept C126322002 @default.
• W2036637468 hasConcept C134018914 @default.
• W2036637468 hasConcept C170493617 @default.
• W2036637468 hasConcept C181199279 @default.
• W2036637468 hasConcept C185592680 @default.
• W2036637468 hasConcept C2775930923 @default.
• W2036637468 hasConcept C2776892390 @default.
• W2036637468 hasConcept C2776929539 @default.
• W2036637468 hasConcept C2779679481 @default.
• W2036637468 hasConcept C2781071845 @default.
• W2036637468 hasConcept C530470458 @default.
• W2036637468 hasConcept C55493867 @default.
• W2036637468 hasConcept C56219504 @default.
• W2036637468 hasConcept C71924100 @default.
• W2036637468 hasConcept C90924648 @default.
• W2036637468 hasConceptScore W2036637468C121608353 @default.
• W2036637468 hasConceptScore W2036637468C126322002 @default.
• W2036637468 hasConceptScore W2036637468C134018914 @default.
• W2036637468 hasConceptScore W2036637468C170493617 @default.
• W2036637468 hasConceptScore W2036637468C181199279 @default.
• W2036637468 hasConceptScore W2036637468C185592680 @default.
• W2036637468 hasConceptScore W2036637468C2775930923 @default.
• W2036637468 hasConceptScore W2036637468C2776892390 @default.
• W2036637468 hasConceptScore W2036637468C2776929539 @default.
• W2036637468 hasConceptScore W2036637468C2779679481 @default.
• W2036637468 hasConceptScore W2036637468C2781071845 @default.
• W2036637468 hasConceptScore W2036637468C530470458 @default.
• W2036637468 hasConceptScore W2036637468C55493867 @default.
• W2036637468 hasConceptScore W2036637468C56219504 @default.
• W2036637468 hasConceptScore W2036637468C71924100 @default.
• W2036637468 hasConceptScore W2036637468C90924648 @default.
• W2036637468 hasIssue "5" @default.
• W2036637468 hasLocation W20366374681 @default.
• W2036637468 hasLocation W20366374682 @default.
• W2036637468 hasOpenAccess W2036637468 @default.
• W2036637468 hasPrimaryLocation W20366374681 @default.
• W2036637468 hasRelatedWork W1566136103 @default.
• W2036637468 hasRelatedWork W1987671886 @default.
• W2036637468 hasRelatedWork W1990913669 @default.
• W2036637468 hasRelatedWork W2082062836 @default.
• W2036637468 hasRelatedWork W2090490091 @default.
• W2036637468 hasRelatedWork W2141123482 @default.
• W2036637468 hasRelatedWork W2200818367 @default.
• W2036637468 hasRelatedWork W2945679884 @default.
• W2036637468 hasRelatedWork W4300014906 @default.
• W2036637468 hasRelatedWork W4308627599 @default.
• W2036637468 hasVolume "1" @default.

• next